Investors can win big when they invest in healthcare stocks that are likely takeover targets. These companies often may not be that profitable, but because of the potential for their products or for their growing revenue, larger companies are willing to pay a premium for them. That often means the purchasing company pays above market price for the target's shares, and investors in the targets are paid well for their patience.

It can be a win-win all around. The larger companies buy some growth while the companies that are being pursued get adopted in a sense by a larger company that may be better equipped to market their products with a greater sales reach.

CRISPR Therapeutics (NASDAQ: CRSP), BioMarin Pharmaceutical (NASDAQ: BMRN), and Sight Sciences (NASDAQ: SGHT) all stand out as potential healthcare stocks that are excellent takeover targets this year. Let's look at why and who might be buying.

Continue reading

Source Fool.com